Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
一项随机、多中心3期研究比较了乙型肝炎疫苗HepB-CpG(HEPLISAV-B®)加强剂与HepB-Eng(Engerix-B®)和HepB-AS04(Fendrix®)在既往接种过乙型肝炎疫苗但未产生血清保护的接受血液透析的成年患者中的免疫原性和安全性:
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2022.2136912
Girndt, Matthias; Plüer, Manfred; Dellanna, Frank; Michelsen, Ann K; Beige, Joachim; Toussaint, Kai; Wehweck, Hubert J; Koch, Michael; Hafezi Rachti, Syrus; Faust, Justus; Bosselmann, Hans-Peter; Witzke, Oliver; Janssen, Robert S